GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

iSpecimen ISPC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.79

-2.97%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About iSpecimen

From its filings with the US Securities and Exchange Commission

SEC filings

iSpecimen is based in Woburn, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ISPC. The SEC classifies its business as commercial physical & biological research. In the fiscal year to 31 December 2025, it reported revenue of $1.9m and a net loss of $10.5m. At that date it held total assets of $9.5m and shareholders' equity of $3.1m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
17 Jun 2021
Employees
75
Head office
8 CABOT ROAD, WOBURN, MA, 08101
Incorporated in
DE
Classification
Services-Commercial Physical & Biological Research
Filer status
<br>Emerging growth company

Leadership

Pay as last reported

  • Ms. Katharyn FieldPresident, since 2024$9,330
  • Mr. Robert LimChief Executive Officer, Treasurer, Secretary, Director, since 2024
  • Ms. Yuying LiangChief Financial Officer
  • Mr. Avtar DhaliwalIndependent Director$8,341
  • Mr. Anthony LauIndependent Director
  • Ms. Siyun YangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Lexington, Massachusetts with 75 employees.
  • IPO occurred on 2021-06-17, indicating market entry.
  • Platform consolidates biospecimen procurement in a single online marketplace.

Weaknesses

  • Company employs only 75 full-time employees, indicating limited workforce.
  • Source description treats facts as untrusted, suggesting potential data reliability issues.
  • Platform relies on de-identified healthcare data provided by supply partners.

Opportunities

  • Platform serves biopharmaceutical companies, IVD companies, and government/academic institutions.
  • Technology transforms biospecimen procurement to accelerate medical discovery.
  • iSpecimen Marketplace has four functional areas: search, workflow, data, and administration.

Threats

  • Source description is untrusted, potentially affecting credibility.
  • Platform depends on healthcare supply partners for data provision.
  • Limited workforce may hinder scalability and growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.